Aortyx
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- $16M
Investors
- 5
About Aortyx
Aortyx specializes in creating solutions for aortic diseases through cutting-edge endovascular devices. Founded in 2018 by Jordi Martorell and Noemí Palasí, the company has undergone significant development to establish its market presence.041 mn. Aortyx provides advanced endovascular devices aimed at treating aortic diseases, focusing on tissue regeneration through a bioresorbable platform. Their flagship product is a regenerative drug delivery system designed to improve patient outcomes, accommodating the specific biomechanical environment of the aorta. The company caters primarily to healthcare institutions, partnering with hospitals and specialized clinics across Europe and North America to ensure effective treatment for vascular conditions.1. The company generates revenue through direct transactions with healthcare providers and medical institutions, focusing on establishing B2B partnerships for its advanced medical devices. Aortyx is committed to meeting its development timelines to ensure the timely introduction of its new product offerings.
Who invested in Aortyx
5 investors across 1 round
See all investors in Aortyx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 12, 2025
Amount
$16M
Investors
Questions about Aortyx
Who invested in Aortyx?
Aortyx has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aortyx raised?
Aortyx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aortyx last raise money?
Aortyx's most recent round on record is a Series A, in Jun 2025.
What does Aortyx do?
Aortyx specializes in creating solutions for aortic diseases through cutting-edge endovascular devices.
Where is Aortyx headquartered?
Aortyx is headquartered in Barcelona, Spain.
Which VCs invest in companies like Aortyx?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Aortyx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aortyx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.